Quantcast

Latest colitis Stories

2011-06-14 05:18:00

UPPER SADDLE RIVER, N.J., June 14, 2011 /PRNewswire/ -- WellApps, Inc. announced today the newest release of GI Monitor, its symptom tracking app for (IBD) Crohn's and Ulcerative Colitis.

2011-06-02 15:56:26

The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.

2011-06-01 00:06:48

On June 25, 2011 the Philadelphia/Delaware Valley Chapter of the Crohn’s & Colitis Foundation of America (CCFA) will host a Zumbathon. Philadelphia, PA (PRWEB) May 31, 2011 On June 25, 2011 at the LifeSport Fitness Resource Center in Philadelphia, the Philadelphia/Delaware Valley Chapter of the Crohn’s & Colitis Foundation of America (CCFA) will host a Zumbathon, the nation’s second event of its kind dedicated to finding cures for Crohn’s disease and...

2011-05-27 14:55:00

SILVER SPRING, Md., May 27, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Dificid (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Clostridium difficile (C.

2011-05-23 22:30:56

Many people tout the beneficial effects of probiotics in preventing and/or treating several intestinal diseases, including ulcerative colitis.

2011-05-19 08:57:00

EXTON, Pa., May 19, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced initiation of a Phase 2 dose-ranging clinical study to evaluate the safety, tolerability, and efficacy of VP 20621 for prevention of recurrence of Clostridium difficile infection (CDI) in adults previously treated for CDI. The objectives of this randomized, double-blind, placebo-controlled, dose ranging study are to evaluate the safety and tolerability of VP 20621 dosed orally for up to 14 days in...

2011-05-18 00:01:30

The Crohn's & Colitis Foundation of America is hosting a live webinar for caregivers, pediatric healthcare professionals, and children and teens with Crohn's disease to address critical issues about managing and coping with disease. New York, NY (PRWEB) May 17, 2011 WHO: This live and interactive webinar will be of interest to children and teens with Crohn’s disease, their caregivers, and healthcare professionals. WHAT: The Crohn's & Colitis Foundation of America is...

2011-05-10 08:00:00

ABBOTT PARK, Ill., May 10, 2011 /PRNewswire/ -- Abbott's (NYSE: ABT) HUMIRA® (adalimumab) met its primary endpoint of clinical remission in a Phase III study of adult patients with moderate to severe ulcerative colitis.

2011-05-09 15:30:00

CHICAGO, May 9, 2011 /PRNewswire/ -- Data from a Phase 3 randomized, multicenter, open-label study demonstrated clinical response with REMICADE® (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC), and showed a safety profile consistent with previous clinical trials conducted in an adult population.

2011-05-06 00:26:42

DNA from Helicobacter pylori, a common stomach bacteria, minimizes the effects of colitis in mice.


Latest colitis Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (1 articles) »
Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.